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In September- 1956 a preliminary report was published
which suggested that intramuscular injections of magnesium
sulphate might have beneficial effects in certain types of
coronary heart disease.1 In particular it was reported that
in a series of 22 cases selected for treatment because of a
high beta-lipoprotein fraction, 14 showed a dramatic reduc-
tion in this fraction after treatment, while clinically 20 of
the 22 cases were markedly improved. Several reports
have since been published which stated that the use of
parenteral magnesium sulphate was clinically justified.:-·
Because of these findings and other suggestive evidence
that magnesium might be associated with atherogenesis, '-8
another trial of the effect of magnesium sulphate was de-
signed. In contrast with the previous trial,l cases were
selected on the soie criterion of suffering from angina of
effort due to coronary heart disease. The effects of mag-
nesium sulphate and a placebo (saline) were compared by
means of the doubl~blind technique. This paper describes
the results obtained.
Material and Methods
Sixteen Patients were included in the trial-ll males and
5 females of ages varying from 44 to 78 years. All had
typical angina of effort; 8' patients had experienced previous
episodes of myocardial infarction; 3 patients suffered also
from myxoedema (induced in 2 as a therapeutic procedure),
3 from moderate diastolic hypertension, and I from diabetes
mellitus. None of the patients had any evidence of any
other type of heart disease, and in all there was an abnormal
electrocardiogram.
Two sets of apparently identical ampoules containing
50% magnesium sulphate or normal saline were labelled
A and B respectively. It was not possible for the person
giving the injections to know which solution was being
used.
Each patient when accepted for trial was allotted treat-
ment A or B in a random manner. The trial was conducted
over a period of 8 weeks. Each patient received a total
of 16 intramuscular injections of I ml. given twice weekly
over 2 consecutive 4-week periods. Half the cases received
solution A (8 injections) followed oy solution B (8 inj~tions),
and the other half solution B followed by solution A.
Blood samples were collected on 5 occasions, immediately
before receiving the 1st, 3rd, 9th and Hth injections and
4 days after the last (16th) injection, The specimens were
collected in the morning approximately 3 hours after a
fat-free breakfast of black tea or coffee and dry toast with
jam. The following investigations were carried out: Total
lipids (Bloor8), total and beta-lipoprotein cholesterol (Sperry
and WebblO), phospholipids (Fiske and Subbarowll), lipo-
proteins (Durrumlt as modified by Bersohn1), and total
fatty acids (Stoddard and DrurylS).
Throughout the trial there was no change in dietary
habits or therapy (thyroid in 3 patients, dicoumarol in 2,
peritrate, metamine, benecardin and phenobarbitone).
All patients kept a record of the incidence of anginal
attacks and of the number of nitrite tablets consumed
each day. At each visit they were asked to report on any
subjective change.
Results
The results of the trial were assessed with regard to sub-
jective change, average weekly consumption of glycerine
trinitrite tablets and biochemical changes.
Of 8 patients who first received sodium chloride all re-
ported subjective improvement. On changing the injections
to magnesium sulphate 5 reported further improvement
(cases I, 3, 6, 7, 8), 2 no change (cases 2 and 4), and one
deterioration (case 5). Of the 8 patients who first received
magnesium sulphate 6 were improved (cases 9, 10, 12, 13,
14, 15). In these the change to placebo injection was accom-
panied by further improvement in 3 (cases 12, 14, 15), and
maintenance of improvement in 3 (cases 9, 10, 13). Two
(cases 11, 16) showed no initial improvement while on
magnesium sulphate injections but reported improvement
on being changed to placebo injection,
As regards biochemical changes the tables reflect the
means of the values observed of the control period on normal
saline (C), and the treatment period on magne ium sul-
phate (T), 0 obviou trends are apparent. The results
were not subjected to tati tical analy is. With the po si-
bility in mind that delayed effect of the magnesium sulphate
injection might be influencing the observed values during
the control period in those subject who received magnesium
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Cholesterol/ I Lipo- AverageTotal Total Phospho- Fatty Beta- protei" Nitrite
Case Alle Sex Lipidr Cholesterot lipidr Acids Phospholipid I Lipo- Cholesterol Tablets/ •- mg.~ mg.~ mg.~ mg·X Ratio protdns mg.% Week----
C I T ---------I-- ------C T C T C T C T C T C T C T---------- ---- ----
l&,d .. .. 59 M 761 909 280 285 262 319 414 522 1·09 ·90 75 77 231 232 3 6
-------------------------------
2b .. .. 50 F 990 1,137 352 379 381 384 512 657 ·92 ·99 76 74 303 32J 2 1-------------------------------
3 .. .. 59 F 798 737 246 231 300 290 478 391 ·82 ·80 64 67 178 171 3 3
-------------------------------
4&,d .. .. 66 M 1,003 896 331 261 339 278 575 545 '98 ·94 82 74 298 216 19 ,9
----------------------I---sa .. .. 46 M 710 864 246 278 295 309 359 489 ·84 ·89 73 74 200 217 I 4
-------------------------------
6c .. .. 52 F 807 903 271 315 314 342 416 486 ·87
~"
74 220 269 9 . 5
---- "268 ----7 .. .. 56 F 969 944 323 211 353 364 530 516 ·92 ·87~ 71 243 3 2
---- ----
8& .. .. 69 M 526 553 179 154 212 219 273 2S5 ·79 ·71 66 67 126 tl2 7 5
278
1
299 ---- --i--Mean .. " 821 867 307 313 445 481 ·90 ·88 73 72 228 224 6 I 4
TABLE n. PATIENTS WHO RECEIVED MAGNESIUM SULPHATE (T) FOLLOWED BY PLACEBO (C)-
I
Beta-
Total Beta- Lipo- .A"tra.~e
Total Total Phospho- Fotty Cholesterol/ Lipo- protdn Nitrite
Case Age Sex Lipidr Cholesterol lipids Acidr Phospholipid proteins Cholesterol Tablets/
mg.% mg.% mg.% mg.% Ratio X mg.% Week
T I C --------------------
__1__
~
T C T C T C T C T C T C T C
------ ----------1-------------
9 .. .. 78 721 756 283 271 260 282 378 383 1'09 ·97 67 70 214 212 5 2
----------------------------~------
10 .. .. 52 M 1,082 1.058 280 277 325 305 688 683 ·86 ·91 79 79 237 235 0 0
-------------------------------
tic .. .. 44 M 754 813 234 257 258 239 440 467 ·92 1·09 69 74 185 202 24 15
I
-------------148"3 ----I-----n-----------\2& .. .. 52 M 963 910 387 345 319 334 512 1·18 1·04 76 338 297 18 10
1-
13& .. .. I 44 M I 793 852 259 281 293 "2901288 472 ·89 ·97 66 72 190 • 230 5 3
14& .. .. I 66 M ~I----ns 224 261 284 293 I367 407 ·79 ·89 67 168" 179 205 12 5
15&,b,c .. I 66 F 7681~ 227 287 266 333 I 390 549 ·83 ·86 69 . 72 189 239 27 20
16 .. ..
r
57 M 650 I 681 239 261 295 277 I309 338 ·84 ·95 68 69 181 205 29 28
Mean .. .. 803 84 269 279 288 294 422 473 ·93 ·96 70 73 214 228 15 10
T=Mean treatment value. C-Mean control value. a=Previous Myocardial infarction. b=Myxoedema. c=Hypertension. d=Diabetes mellitus.
sulphate first, another set of tables was prepared. In these
the blood value obtained before the magnesium sulphate
injections was compared with the blood value obtained at
the end of one month's magnesium sulphate treatment.
Again no obvious trends were discernible.
DlSCUSSIO
The principal criterion by which subjects were selected for
this trial was the presence of repeated typical angina of
effort due to atherosclerosis. Although this selection
makes the as essment of subjective effects easier it renders
assessment of blood lipid studies more difficult.
Thus the series included 3 cases with myxoedema, 1 with
diabetes mellitus, and 3 with some degree of hypertension.
The initial cholesterol, lipid and lipoprotein values were
not gros Iy abnormal in all cases and were strictly normal
in every respect in one (case 8). The percentage beta-lipo-
protein was elevated above 75 in only 4- cases. This con-
trasts with the series of Malkiel-Shapiro and Bersohn in
which all cases without an elevation of the percentage beta-
lipoprotein were excluded. The results of the 2 series are
therefore not comparable. In our eries there was a reduction
of more than 25 mg. % in the level of beta-cholesterol in
5 patients (cases 4, 7, 13, 14, 15). If a reduction of 50 mg. %
or more is taken, only 2 patients (cases 4 and 15) can be
included. However, consideration of the group means
shows that there were no very striking trends in any of the
values examined as a result of treatment with magnesium
sulphate.
The injections of magnesium sulphate were no more
painful than the saline, and the subjects were in no instance
aware of the change from one to the other.
As regards subjective improvement, it is well known
that the institution of any active treatment produces apparent
subjective benefit in patients with chronic illness. This
placebo-induced improvement renders any attempt at
assessment of drug therapy most difficult. Because of this
a large number of subjects must be studied to show significant
differences, and a blind or preferably a double-blind tech-
nique, as was employed here, is essential. One can only
conclude that this series was too small to disprove the possi-
bility of subjective benefit. There was, however, no difference
in the frequency and degree of subjective improvement
following each of the 2 substances given. Brigden14 sum-
marizes the situation neatly when he says:
'It is not always realized that myocardial ischaemia shows an
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inherent tendency to improve over long periods of time, especi-
ally in patients who are able to adjust their minds and life situa-
tion to the disease. Many observers have noted that when a
patient is started on any new form of treatment improvement is
almost invariably the rule. The conclusion cannot be escaped
that psychological factors as weD as many physical ones are of
importance. An understanding doctor-patient relationship is as
important in this disease as in any condition in the whole field
of medical practice.'
SUMMARY
Sixteen patients suffering from coronary artery disease and
typical angina of effort received courses of magnesium
sulphate and a placebo using a double-blind technique.
No very strilcitJg trends were observable in the pattern of
blood lipids or lipoproteins though 5 individual cases
showed reductions of beta-eholesterol which were possibly
significant. Subjective improvement was very great with
magnesium sulphate but just as great with the placebo.
The results of this series do not conflict with those of Malkiel-
Shapiro and Bersohn, who used different criteria for the
selection of cases.
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